A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TBX1
|
ENSG00000184058.8 | T-box transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TBX1 | hg19_v2_chr22_+_19744226_19744226 | 0.70 | 1.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_34662651 | 1.13 |
ENST00000259631.4
|
CCL27
|
chemokine (C-C motif) ligand 27 |
chr19_-_51875894 | 1.05 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr17_+_74846230 | 0.99 |
ENST00000592919.1
|
LINC00868
|
long intergenic non-protein coding RNA 868 |
chr11_+_107650219 | 0.81 |
ENST00000398067.1
|
AP001024.1
|
Uncharacterized protein |
chr12_-_66317967 | 0.78 |
ENST00000601398.1
|
AC090673.2
|
Uncharacterized protein |
chr19_+_544034 | 0.76 |
ENST00000592501.1
ENST00000264553.3 |
GZMM
|
granzyme M (lymphocyte met-ase 1) |
chr12_-_58145889 | 0.73 |
ENST00000547853.1
|
CDK4
|
cyclin-dependent kinase 4 |
chr7_+_74191613 | 0.69 |
ENST00000442021.2
|
NCF1
|
neutrophil cytosolic factor 1 |
chr1_+_89829610 | 0.69 |
ENST00000370456.4
ENST00000535065.1 |
GBP6
|
guanylate binding protein family, member 6 |
chr11_+_73358690 | 0.68 |
ENST00000545798.1
ENST00000539157.1 ENST00000546251.1 ENST00000535582.1 ENST00000538227.1 ENST00000543524.1 |
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr16_-_28550320 | 0.65 |
ENST00000395641.2
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr4_+_2626988 | 0.64 |
ENST00000509050.1
|
FAM193A
|
family with sequence similarity 193, member A |
chr20_+_1115821 | 0.63 |
ENST00000435720.1
|
PSMF1
|
proteasome (prosome, macropain) inhibitor subunit 1 (PI31) |
chr5_-_86534822 | 0.59 |
ENST00000445770.2
|
AC008394.1
|
Uncharacterized protein |
chr11_+_73661364 | 0.57 |
ENST00000339764.1
|
DNAJB13
|
DnaJ (Hsp40) homolog, subfamily B, member 13 |
chr1_-_219615984 | 0.57 |
ENST00000420762.1
|
RP11-95P13.1
|
RP11-95P13.1 |
chr18_-_59274139 | 0.56 |
ENST00000586949.1
|
RP11-879F14.2
|
RP11-879F14.2 |
chr11_-_1606513 | 0.56 |
ENST00000382171.2
|
KRTAP5-1
|
keratin associated protein 5-1 |
chr2_-_228579305 | 0.55 |
ENST00000456524.1
|
SLC19A3
|
solute carrier family 19 (thiamine transporter), member 3 |
chr11_-_74204692 | 0.54 |
ENST00000528085.1
|
LIPT2
|
lipoyl(octanoyl) transferase 2 (putative) |
chr7_-_76255444 | 0.53 |
ENST00000454397.1
|
POMZP3
|
POM121 and ZP3 fusion |
chr4_-_90757364 | 0.53 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr1_+_19967014 | 0.53 |
ENST00000428975.1
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist |
chr11_+_44087862 | 0.52 |
ENST00000432284.2
|
ACCS
|
1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional) |
chr17_-_67323385 | 0.51 |
ENST00000588665.1
|
ABCA5
|
ATP-binding cassette, sub-family A (ABC1), member 5 |
chr2_+_113479063 | 0.48 |
ENST00000327581.4
|
NT5DC4
|
5'-nucleotidase domain containing 4 |
chr19_+_36027660 | 0.47 |
ENST00000585510.1
|
GAPDHS
|
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic |
chr16_-_28550348 | 0.45 |
ENST00000324873.6
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr13_+_111837279 | 0.45 |
ENST00000467053.1
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
chr19_+_10527449 | 0.44 |
ENST00000592685.1
ENST00000380702.2 |
PDE4A
|
phosphodiesterase 4A, cAMP-specific |
chr11_-_76155618 | 0.44 |
ENST00000530759.1
|
RP11-111M22.3
|
RP11-111M22.3 |
chr8_-_73793975 | 0.44 |
ENST00000523881.1
|
RP11-1145L24.1
|
RP11-1145L24.1 |
chr20_+_62492566 | 0.44 |
ENST00000369916.3
|
ABHD16B
|
abhydrolase domain containing 16B |
chr19_-_2090131 | 0.43 |
ENST00000591326.1
|
MOB3A
|
MOB kinase activator 3A |
chr12_+_79357815 | 0.42 |
ENST00000547046.1
|
SYT1
|
synaptotagmin I |
chr17_-_66097610 | 0.42 |
ENST00000584047.1
ENST00000579629.1 |
AC145343.2
|
AC145343.2 |
chr19_-_43702231 | 0.42 |
ENST00000597374.1
ENST00000599371.1 |
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
chr2_+_242913327 | 0.42 |
ENST00000426962.1
|
AC093642.3
|
AC093642.3 |
chr7_+_99724317 | 0.42 |
ENST00000398075.2
ENST00000421390.1 |
MBLAC1
|
metallo-beta-lactamase domain containing 1 |
chr17_-_36884451 | 0.42 |
ENST00000595377.1
|
AC006449.1
|
NS5ATP13TP1; Uncharacterized protein |
chr10_-_16563870 | 0.41 |
ENST00000298943.3
|
C1QL3
|
complement component 1, q subcomponent-like 3 |
chr4_+_156680153 | 0.41 |
ENST00000502959.1
ENST00000505764.1 ENST00000507146.1 ENST00000264424.8 ENST00000503520.1 |
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
chr7_-_20826504 | 0.41 |
ENST00000418710.2
ENST00000361443.4 |
SP8
|
Sp8 transcription factor |
chr6_-_30685214 | 0.41 |
ENST00000425072.1
|
MDC1
|
mediator of DNA-damage checkpoint 1 |
chr11_-_111649074 | 0.41 |
ENST00000534218.1
|
RP11-108O10.2
|
RP11-108O10.2 |
chr1_+_109642799 | 0.40 |
ENST00000602755.1
|
SCARNA2
|
small Cajal body-specific RNA 2 |
chr11_-_60010556 | 0.40 |
ENST00000427611.2
|
MS4A4E
|
membrane-spanning 4-domains, subfamily A, member 4E |
chr15_+_82380974 | 0.40 |
ENST00000559788.1
ENST00000557838.1 |
RP11-597K23.2
|
Uncharacterized protein |
chr11_+_44087729 | 0.40 |
ENST00000524990.1
ENST00000263776.8 |
ACCS
|
1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional) |
chr18_-_8337038 | 0.40 |
ENST00000594251.1
|
AP001094.1
|
Uncharacterized protein |
chr1_-_17676070 | 0.39 |
ENST00000602074.1
|
AC004824.2
|
Uncharacterized protein |
chr19_+_56915668 | 0.39 |
ENST00000333201.9
ENST00000391778.3 |
ZNF583
|
zinc finger protein 583 |
chr12_+_75874984 | 0.38 |
ENST00000550491.1
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr11_+_61447845 | 0.38 |
ENST00000257215.5
|
DAGLA
|
diacylglycerol lipase, alpha |
chr20_-_52612705 | 0.37 |
ENST00000434986.2
|
BCAS1
|
breast carcinoma amplified sequence 1 |
chr3_+_195413160 | 0.37 |
ENST00000599448.1
|
LINC00969
|
long intergenic non-protein coding RNA 969 |
chr5_-_137514333 | 0.37 |
ENST00000411594.2
ENST00000430331.1 |
BRD8
|
bromodomain containing 8 |
chr19_+_37341752 | 0.37 |
ENST00000586933.1
ENST00000532141.1 ENST00000420450.1 ENST00000526123.1 |
ZNF345
|
zinc finger protein 345 |
chr19_+_17337027 | 0.37 |
ENST00000601529.1
ENST00000600232.1 |
OCEL1
|
occludin/ELL domain containing 1 |
chr3_+_156807663 | 0.37 |
ENST00000467995.1
ENST00000474477.1 ENST00000471719.1 |
LINC00881
|
long intergenic non-protein coding RNA 881 |
chr9_+_133986782 | 0.37 |
ENST00000372301.2
|
AIF1L
|
allograft inflammatory factor 1-like |
chr11_+_58938903 | 0.35 |
ENST00000532982.1
|
DTX4
|
deltex homolog 4 (Drosophila) |
chr7_-_99680171 | 0.35 |
ENST00000428683.1
|
ZNF3
|
zinc finger protein 3 |
chr12_+_65672702 | 0.35 |
ENST00000538045.1
ENST00000535239.1 |
MSRB3
|
methionine sulfoxide reductase B3 |
chr5_+_67535647 | 0.35 |
ENST00000520675.1
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
chr11_-_441964 | 0.35 |
ENST00000332826.6
|
ANO9
|
anoctamin 9 |
chr19_+_35634146 | 0.35 |
ENST00000586063.1
ENST00000270310.2 ENST00000588265.1 |
FXYD7
|
FXYD domain containing ion transport regulator 7 |
chr1_+_17906970 | 0.35 |
ENST00000375415.1
|
ARHGEF10L
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr18_+_20378191 | 0.33 |
ENST00000583700.1
|
RBBP8
|
retinoblastoma binding protein 8 |
chr19_+_17337007 | 0.33 |
ENST00000215061.4
|
OCEL1
|
occludin/ELL domain containing 1 |
chr16_-_740354 | 0.33 |
ENST00000293883.4
|
WDR24
|
WD repeat domain 24 |
chr3_-_53080672 | 0.33 |
ENST00000483069.1
|
SFMBT1
|
Scm-like with four mbt domains 1 |
chr8_-_61880248 | 0.33 |
ENST00000525556.1
|
AC022182.3
|
AC022182.3 |
chr5_-_149669612 | 0.33 |
ENST00000510347.1
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha |
chr22_+_35776354 | 0.33 |
ENST00000412893.1
|
HMOX1
|
heme oxygenase (decycling) 1 |
chr1_+_44679159 | 0.33 |
ENST00000315913.5
ENST00000372289.2 |
DMAP1
|
DNA methyltransferase 1 associated protein 1 |
chr2_+_10560147 | 0.33 |
ENST00000422133.1
|
HPCAL1
|
hippocalcin-like 1 |
chr12_-_120241187 | 0.33 |
ENST00000392520.2
|
CIT
|
citron (rho-interacting, serine/threonine kinase 21) |
chr21_-_44582378 | 0.33 |
ENST00000433840.1
|
AP001631.10
|
AP001631.10 |
chr10_+_135204338 | 0.32 |
ENST00000468317.2
|
RP11-108K14.8
|
Mitochondrial GTPase 1 |
chr1_+_26503894 | 0.32 |
ENST00000361530.6
ENST00000374253.5 |
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1 |
chr9_-_117267717 | 0.32 |
ENST00000374057.3
|
DFNB31
|
deafness, autosomal recessive 31 |
chr6_+_159071015 | 0.32 |
ENST00000360448.3
|
SYTL3
|
synaptotagmin-like 3 |
chr17_-_7080227 | 0.32 |
ENST00000574330.1
|
ASGR1
|
asialoglycoprotein receptor 1 |
chr1_+_154378049 | 0.32 |
ENST00000512471.1
|
IL6R
|
interleukin 6 receptor |
chr5_+_150639360 | 0.31 |
ENST00000523004.1
|
GM2A
|
GM2 ganglioside activator |
chr4_+_183065793 | 0.31 |
ENST00000512480.1
|
TENM3
|
teneurin transmembrane protein 3 |
chr14_+_67291158 | 0.31 |
ENST00000555456.1
|
GPHN
|
gephyrin |
chr22_-_31688431 | 0.30 |
ENST00000402249.3
ENST00000443175.1 ENST00000215912.5 ENST00000441972.1 |
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr11_-_3186551 | 0.30 |
ENST00000533234.1
|
OSBPL5
|
oxysterol binding protein-like 5 |
chr3_+_40547483 | 0.30 |
ENST00000420891.1
ENST00000314529.6 ENST00000418905.1 |
ZNF620
|
zinc finger protein 620 |
chr2_-_157189180 | 0.30 |
ENST00000539077.1
ENST00000424077.1 ENST00000426264.1 ENST00000339562.4 ENST00000421709.1 |
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
chr7_+_99036996 | 0.30 |
ENST00000441580.1
ENST00000412686.1 |
CPSF4
|
cleavage and polyadenylation specific factor 4, 30kDa |
chr12_-_14924056 | 0.30 |
ENST00000539745.1
|
HIST4H4
|
histone cluster 4, H4 |
chr17_-_39538550 | 0.30 |
ENST00000394001.1
|
KRT34
|
keratin 34 |
chr19_-_13900972 | 0.30 |
ENST00000397557.1
|
AC008686.1
|
Uncharacterized protein |
chr1_+_156698743 | 0.30 |
ENST00000524343.1
|
RRNAD1
|
ribosomal RNA adenine dimethylase domain containing 1 |
chr15_-_73075964 | 0.30 |
ENST00000563907.1
|
ADPGK
|
ADP-dependent glucokinase |
chr1_-_114429997 | 0.30 |
ENST00000471267.1
ENST00000393320.3 |
BCL2L15
|
BCL2-like 15 |
chr1_-_156269428 | 0.30 |
ENST00000339922.3
|
VHLL
|
von Hippel-Lindau tumor suppressor-like |
chr17_-_7232585 | 0.29 |
ENST00000571887.1
ENST00000315614.7 ENST00000399464.2 ENST00000570460.1 |
NEURL4
|
neuralized E3 ubiquitin protein ligase 4 |
chr9_-_95055923 | 0.29 |
ENST00000430417.1
|
IARS
|
isoleucyl-tRNA synthetase |
chr4_-_146859623 | 0.29 |
ENST00000379448.4
ENST00000513320.1 |
ZNF827
|
zinc finger protein 827 |
chr19_+_35225121 | 0.29 |
ENST00000595708.1
ENST00000593781.1 |
ZNF181
|
zinc finger protein 181 |
chr14_+_95047744 | 0.29 |
ENST00000553511.1
ENST00000554633.1 ENST00000555681.1 ENST00000554276.1 |
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
chr6_-_15548591 | 0.29 |
ENST00000509674.1
|
DTNBP1
|
dystrobrevin binding protein 1 |
chr11_+_129936836 | 0.29 |
ENST00000597197.1
|
AP003041.2
|
Uncharacterized protein |
chr19_+_19779589 | 0.29 |
ENST00000541458.1
|
ZNF101
|
zinc finger protein 101 |
chr3_+_9691117 | 0.29 |
ENST00000353332.5
ENST00000420925.1 ENST00000296003.4 ENST00000351233.5 |
MTMR14
|
myotubularin related protein 14 |
chr17_-_72619869 | 0.29 |
ENST00000392619.1
ENST00000426295.2 |
CD300E
|
CD300e molecule |
chr18_+_13612613 | 0.28 |
ENST00000586765.1
|
LDLRAD4
|
low density lipoprotein receptor class A domain containing 4 |
chr6_-_31619892 | 0.28 |
ENST00000454165.1
ENST00000428326.1 ENST00000452994.1 |
BAG6
|
BCL2-associated athanogene 6 |
chr5_-_132113690 | 0.28 |
ENST00000414594.1
|
SEPT8
|
septin 8 |
chr19_+_44331555 | 0.28 |
ENST00000590950.1
|
ZNF283
|
zinc finger protein 283 |
chr19_-_10420459 | 0.28 |
ENST00000403352.1
ENST00000403903.3 |
ZGLP1
|
zinc finger, GATA-like protein 1 |
chr3_-_127317047 | 0.28 |
ENST00000462228.1
ENST00000490643.1 |
TPRA1
|
transmembrane protein, adipocyte asscociated 1 |
chr4_+_159727272 | 0.28 |
ENST00000379346.3
|
FNIP2
|
folliculin interacting protein 2 |
chr19_-_46526304 | 0.28 |
ENST00000008938.4
|
PGLYRP1
|
peptidoglycan recognition protein 1 |
chr19_+_3762645 | 0.28 |
ENST00000330133.4
|
MRPL54
|
mitochondrial ribosomal protein L54 |
chr19_+_45445524 | 0.28 |
ENST00000591600.1
|
APOC4
|
apolipoprotein C-IV |
chr1_+_156211753 | 0.28 |
ENST00000368272.4
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein |
chr20_+_34680595 | 0.28 |
ENST00000406771.2
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr11_+_818902 | 0.28 |
ENST00000336615.4
|
PNPLA2
|
patatin-like phospholipase domain containing 2 |
chr7_-_30009542 | 0.28 |
ENST00000438497.1
|
SCRN1
|
secernin 1 |
chr6_-_75828774 | 0.27 |
ENST00000493109.2
|
COL12A1
|
collagen, type XII, alpha 1 |
chr14_+_23727694 | 0.27 |
ENST00000399905.1
ENST00000470456.1 |
C14orf164
|
chromosome 14 open reading frame 164 |
chr12_-_26278030 | 0.27 |
ENST00000242728.4
|
BHLHE41
|
basic helix-loop-helix family, member e41 |
chr12_+_50017184 | 0.27 |
ENST00000548825.2
|
PRPF40B
|
PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae) |
chr17_+_39994032 | 0.27 |
ENST00000293303.4
ENST00000438813.1 |
KLHL10
|
kelch-like family member 10 |
chr22_-_36600727 | 0.26 |
ENST00000397275.2
ENST00000328429.4 |
APOL4
|
apolipoprotein L, 4 |
chr14_-_75330537 | 0.26 |
ENST00000556084.2
ENST00000556489.2 ENST00000445876.1 |
PROX2
|
prospero homeobox 2 |
chr4_+_159727222 | 0.26 |
ENST00000512986.1
|
FNIP2
|
folliculin interacting protein 2 |
chr9_-_96717654 | 0.26 |
ENST00000253968.6
|
BARX1
|
BARX homeobox 1 |
chr3_+_126423045 | 0.26 |
ENST00000290913.3
ENST00000508789.1 |
CHCHD6
|
coiled-coil-helix-coiled-coil-helix domain containing 6 |
chr19_-_46580352 | 0.26 |
ENST00000601672.1
|
IGFL4
|
IGF-like family member 4 |
chr8_-_27457494 | 0.26 |
ENST00000521770.1
|
CLU
|
clusterin |
chr6_-_85473073 | 0.26 |
ENST00000606621.1
|
TBX18
|
T-box 18 |
chr5_+_176514413 | 0.26 |
ENST00000513166.1
|
FGFR4
|
fibroblast growth factor receptor 4 |
chr5_-_138780159 | 0.26 |
ENST00000512473.1
ENST00000515581.1 ENST00000515277.1 |
DNAJC18
|
DnaJ (Hsp40) homolog, subfamily C, member 18 |
chr2_-_95831158 | 0.26 |
ENST00000447814.1
|
ZNF514
|
zinc finger protein 514 |
chr1_-_156399184 | 0.26 |
ENST00000368243.1
ENST00000357975.4 ENST00000310027.5 ENST00000400991.2 |
C1orf61
|
chromosome 1 open reading frame 61 |
chr20_-_3762087 | 0.26 |
ENST00000379756.3
|
SPEF1
|
sperm flagellar 1 |
chr7_-_72972319 | 0.26 |
ENST00000223368.2
|
BCL7B
|
B-cell CLL/lymphoma 7B |
chr2_-_103353277 | 0.26 |
ENST00000258436.5
|
MFSD9
|
major facilitator superfamily domain containing 9 |
chr4_-_46911223 | 0.25 |
ENST00000396533.1
|
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
chr6_-_26124138 | 0.25 |
ENST00000314332.5
ENST00000396984.1 |
HIST1H2BC
|
histone cluster 1, H2bc |
chr15_+_59908633 | 0.25 |
ENST00000559626.1
|
GCNT3
|
glucosaminyl (N-acetyl) transferase 3, mucin type |
chr20_+_2796948 | 0.25 |
ENST00000361033.1
ENST00000380585.1 |
TMEM239
|
transmembrane protein 239 |
chr10_+_135160844 | 0.25 |
ENST00000423766.1
ENST00000458230.1 |
PRAP1
|
proline-rich acidic protein 1 |
chr9_+_140119618 | 0.25 |
ENST00000359069.2
|
C9orf169
|
chromosome 9 open reading frame 169 |
chr4_+_185395947 | 0.25 |
ENST00000605834.1
|
RP11-326I11.3
|
RP11-326I11.3 |
chr16_-_740419 | 0.25 |
ENST00000248142.6
|
WDR24
|
WD repeat domain 24 |
chr12_-_13529594 | 0.25 |
ENST00000539026.1
|
C12orf36
|
chromosome 12 open reading frame 36 |
chr4_+_169575875 | 0.25 |
ENST00000503457.1
|
PALLD
|
palladin, cytoskeletal associated protein |
chr3_-_141868293 | 0.25 |
ENST00000317104.7
ENST00000494358.1 |
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr17_+_7210294 | 0.25 |
ENST00000336452.7
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr15_+_76016293 | 0.25 |
ENST00000332145.2
|
ODF3L1
|
outer dense fiber of sperm tails 3-like 1 |
chr13_+_24844857 | 0.25 |
ENST00000409126.1
ENST00000343003.6 |
SPATA13
|
spermatogenesis associated 13 |
chr16_+_855443 | 0.25 |
ENST00000301698.1
|
PRR25
|
proline rich 25 |
chr4_+_619347 | 0.24 |
ENST00000255622.6
|
PDE6B
|
phosphodiesterase 6B, cGMP-specific, rod, beta |
chr1_+_156698708 | 0.24 |
ENST00000519086.1
|
RRNAD1
|
ribosomal RNA adenine dimethylase domain containing 1 |
chrX_-_153279697 | 0.24 |
ENST00000444254.1
|
IRAK1
|
interleukin-1 receptor-associated kinase 1 |
chr22_+_35776828 | 0.24 |
ENST00000216117.8
|
HMOX1
|
heme oxygenase (decycling) 1 |
chr6_-_13487825 | 0.24 |
ENST00000603223.1
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1 |
chr11_+_86511549 | 0.24 |
ENST00000533902.2
|
PRSS23
|
protease, serine, 23 |
chrX_-_54069576 | 0.24 |
ENST00000445025.1
ENST00000322659.8 |
PHF8
|
PHD finger protein 8 |
chr5_-_137514617 | 0.24 |
ENST00000254900.5
|
BRD8
|
bromodomain containing 8 |
chr19_+_10397648 | 0.24 |
ENST00000340992.4
ENST00000393717.2 |
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
chr9_-_35812140 | 0.24 |
ENST00000497810.1
ENST00000396638.2 ENST00000484764.1 |
SPAG8
|
sperm associated antigen 8 |
chr19_-_54676846 | 0.24 |
ENST00000301187.4
|
TMC4
|
transmembrane channel-like 4 |
chr3_+_137728842 | 0.24 |
ENST00000183605.5
|
CLDN18
|
claudin 18 |
chr16_+_83932684 | 0.24 |
ENST00000262430.4
|
MLYCD
|
malonyl-CoA decarboxylase |
chr17_-_79623597 | 0.24 |
ENST00000574024.1
ENST00000331056.5 |
PDE6G
|
phosphodiesterase 6G, cGMP-specific, rod, gamma |
chr7_+_99816859 | 0.24 |
ENST00000317271.2
|
PVRIG
|
poliovirus receptor related immunoglobulin domain containing |
chr6_+_49518113 | 0.24 |
ENST00000529246.2
|
C6orf141
|
chromosome 6 open reading frame 141 |
chr1_+_28285973 | 0.24 |
ENST00000373884.5
|
XKR8
|
XK, Kell blood group complex subunit-related family, member 8 |
chr11_-_47736896 | 0.24 |
ENST00000525123.1
ENST00000528244.1 ENST00000532595.1 ENST00000529154.1 ENST00000530969.1 |
AGBL2
|
ATP/GTP binding protein-like 2 |
chr13_+_24844819 | 0.24 |
ENST00000399949.2
|
SPATA13
|
spermatogenesis associated 13 |
chr5_-_137514288 | 0.24 |
ENST00000454473.1
ENST00000418329.1 ENST00000455658.2 ENST00000230901.5 ENST00000402931.1 |
BRD8
|
bromodomain containing 8 |
chr12_+_110011571 | 0.24 |
ENST00000539696.1
ENST00000228510.3 ENST00000392727.3 |
MVK
|
mevalonate kinase |
chr17_+_26662679 | 0.24 |
ENST00000578158.1
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr1_-_168513229 | 0.24 |
ENST00000367819.2
|
XCL2
|
chemokine (C motif) ligand 2 |
chr11_+_66824346 | 0.23 |
ENST00000532559.1
|
RHOD
|
ras homolog family member D |
chr3_+_142315294 | 0.23 |
ENST00000464320.1
|
PLS1
|
plastin 1 |
chr4_-_90756769 | 0.23 |
ENST00000345009.4
ENST00000505199.1 ENST00000502987.1 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr1_-_183538319 | 0.23 |
ENST00000420553.1
ENST00000419402.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr6_-_30684898 | 0.23 |
ENST00000422266.1
ENST00000416571.1 |
MDC1
|
mediator of DNA-damage checkpoint 1 |
chr16_+_27226256 | 0.23 |
ENST00000567735.1
|
KDM8
|
lysine (K)-specific demethylase 8 |
chr4_+_108746282 | 0.23 |
ENST00000503862.1
|
SGMS2
|
sphingomyelin synthase 2 |
chr19_-_48389651 | 0.23 |
ENST00000222002.3
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
chr2_+_102618428 | 0.23 |
ENST00000457817.1
|
IL1R2
|
interleukin 1 receptor, type II |
chr17_+_80816395 | 0.23 |
ENST00000576160.2
ENST00000571712.1 |
TBCD
|
tubulin folding cofactor D |
chr3_-_52443799 | 0.23 |
ENST00000470173.1
ENST00000296288.5 |
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) |
chr1_+_182758900 | 0.23 |
ENST00000367555.1
ENST00000367554.3 |
NPL
|
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) |
chr7_+_12250943 | 0.23 |
ENST00000442107.1
|
TMEM106B
|
transmembrane protein 106B |
chr16_+_85932760 | 0.23 |
ENST00000565552.1
|
IRF8
|
interferon regulatory factor 8 |
chr16_-_86588627 | 0.23 |
ENST00000565482.1
ENST00000564364.1 ENST00000561989.1 ENST00000543303.2 ENST00000381214.5 ENST00000360900.6 ENST00000322911.6 ENST00000546093.1 ENST00000569000.1 ENST00000562994.1 ENST00000561522.1 |
MTHFSD
|
methenyltetrahydrofolate synthetase domain containing |
chr17_-_8066843 | 0.23 |
ENST00000404970.3
|
VAMP2
|
vesicle-associated membrane protein 2 (synaptobrevin 2) |
chr19_-_3761673 | 0.23 |
ENST00000316757.3
|
APBA3
|
amyloid beta (A4) precursor protein-binding, family A, member 3 |
chr19_+_55987998 | 0.23 |
ENST00000591164.1
|
ZNF628
|
zinc finger protein 628 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | GO:0051621 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 0.6 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.7 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.1 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.4 | GO:0043132 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) NAD transport(GO:0043132) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.1 | 0.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.4 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.1 | 0.5 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.1 | 0.6 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 0.6 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 0.3 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.7 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.1 | 0.2 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.1 | 0.3 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 0.4 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.1 | 0.5 | GO:1903412 | response to bile acid(GO:1903412) |
0.1 | 0.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 0.3 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.9 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 0.3 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.1 | 0.3 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 0.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.1 | 0.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.3 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 0.3 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.3 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.4 | GO:0061015 | snRNA import into nucleus(GO:0061015) |
0.1 | 0.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 0.6 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.1 | 0.2 | GO:1903465 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.1 | 0.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.1 | 0.1 | GO:0048242 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
0.1 | 0.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.1 | 0.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.4 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 0.3 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.3 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
0.1 | 1.0 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.2 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.1 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.3 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.2 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 0.1 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.1 | 0.2 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.0 | 0.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 0.1 | GO:0061010 | negative regulation of transcription by transcription factor localization(GO:0010621) gall bladder development(GO:0061010) |
0.0 | 0.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.0 | 0.2 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.0 | 0.2 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.0 | 0.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.0 | 0.2 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.0 | 0.2 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.5 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.1 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.0 | 0.0 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.0 | 0.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.0 | 0.1 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.0 | 0.1 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.0 | 0.4 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.1 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.1 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.0 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.0 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.2 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.0 | 0.2 | GO:0051586 | peptidyl-cysteine methylation(GO:0018125) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.2 | GO:0039656 | modulation by virus of host transcription(GO:0019056) modulation by virus of host gene expression(GO:0039656) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.0 | 1.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.3 | GO:0019075 | virus maturation(GO:0019075) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.0 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.0 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.2 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.0 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.0 | 0.2 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.0 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.0 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.0 | 0.3 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.0 | 0.1 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.0 | 0.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.0 | 0.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.3 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.0 | 0.1 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.0 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.0 | 0.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.0 | 0.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.1 | GO:0016487 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
0.0 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.1 | GO:1900738 | dense core granule biogenesis(GO:0061110) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
0.0 | 0.1 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
0.0 | 0.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.0 | 0.1 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.0 | 0.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:1903939 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of TORC2 signaling(GO:1903939) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.1 | GO:1903979 | negative regulation of microglial cell activation(GO:1903979) |
0.0 | 0.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 0.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 0.1 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.3 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.1 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.2 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.0 | 0.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.1 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.0 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.1 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.0 | 0.2 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.1 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.0 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.3 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.1 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.0 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.7 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.4 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.0 | 0.1 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.0 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.5 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.0 | 0.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.0 | 0.2 | GO:0051510 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.0 | 0.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.0 | 0.6 | GO:0051197 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.1 | GO:1903824 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.1 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
0.0 | 0.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.1 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.0 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.1 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.0 | 0.1 | GO:1904647 | response to rotenone(GO:1904647) |
0.0 | 0.2 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.0 | 0.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0048864 | stem cell development(GO:0048864) |
0.0 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.0 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.0 | 0.1 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.0 | 0.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.0 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.4 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.0 | 0.0 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.0 | 0.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.1 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.0 | 0.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.1 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.0 | 0.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.0 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.0 | 0.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.1 | GO:0042704 | uterine wall breakdown(GO:0042704) |
0.0 | 0.1 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.0 | 0.1 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.0 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) alanine transport(GO:0032328) |
0.0 | 0.5 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.2 | GO:0061098 | regulation of protein tyrosine kinase activity(GO:0061097) positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.5 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.1 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.0 | 0.1 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.0 | 0.2 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 0.8 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.1 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.0 | 0.7 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.0 | 0.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.0 | 0.1 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.0 | 0.3 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.1 | GO:0006751 | glutathione catabolic process(GO:0006751) leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.4 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.0 | 0.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:0043542 | endothelial cell migration(GO:0043542) |
0.0 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0046449 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) |
0.0 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.0 | 0.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.1 | GO:0030047 | actin modification(GO:0030047) |
0.0 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.0 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.0 | 0.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.0 | GO:0033590 | acetaldehyde metabolic process(GO:0006117) response to cobalamin(GO:0033590) |
0.0 | 0.1 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0030299 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.1 | GO:0097035 | phospholipid scrambling(GO:0017121) regulation of membrane lipid distribution(GO:0097035) |
0.0 | 0.3 | GO:0021543 | pallium development(GO:0021543) |
0.0 | 0.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.0 | 0.1 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.3 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.0 | 0.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.0 | 0.1 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 0.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.2 | GO:0006096 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
0.0 | 0.3 | GO:0010226 | response to lithium ion(GO:0010226) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.0 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.0 | 0.3 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.0 | 0.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.0 | 0.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.1 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.0 | 0.1 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
0.0 | 0.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.0 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.0 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.1 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.0 | 0.0 | GO:0061386 | noradrenergic neuron differentiation(GO:0003357) closure of optic fissure(GO:0061386) |
0.0 | 0.0 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.0 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.0 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.0 | 0.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.1 | GO:0044539 | response to oleic acid(GO:0034201) long-chain fatty acid import(GO:0044539) |
0.0 | 0.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 1.2 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.0 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.2 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.0 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.1 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.0 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.0 | 0.1 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.0 | 0.1 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.0 | 0.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.6 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.0 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.0 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.3 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.9 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.3 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 0.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.3 | GO:0036029 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.1 | 0.3 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 0.2 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.1 | 0.2 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.1 | 0.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.7 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 0.1 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.1 | 0.2 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.4 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.0 | 0.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.4 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.2 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.0 | 0.1 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.1 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
0.0 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0036457 | keratohyalin granule(GO:0036457) |
0.0 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.0 | 0.7 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.5 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.6 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0070702 | inner mucus layer(GO:0070702) outer mucus layer(GO:0070703) |
0.0 | 0.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.0 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.0 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.1 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.3 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.2 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.0 | GO:0036284 | tubulobulbar complex(GO:0036284) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.2 | 0.8 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.2 | 0.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.6 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.6 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.1 | 0.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.4 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.1 | 0.4 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.1 | 0.7 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 0.3 | GO:0061598 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.1 | 0.3 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.1 | 0.3 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 0.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 0.4 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.1 | 0.4 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.1 | 0.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.3 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.1 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.2 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.1 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.2 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 1.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.2 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.1 | 0.2 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.1 | 0.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.2 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.2 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.1 | 0.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.0 | 0.2 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.0 | 1.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.2 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.0 | 0.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.2 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.0 | 0.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.0 | 0.2 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.0 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.0 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.0 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.0 | 0.3 | GO:0032810 | sterol response element binding(GO:0032810) |
0.0 | 0.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.2 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.0 | 0.1 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.0 | 0.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.2 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.0 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.1 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.0 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:1901474 | azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.2 | GO:0005328 | neurotransmitter transporter activity(GO:0005326) neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.2 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.0 | 0.1 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.0 | 0.1 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.0 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.0 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 0.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.0 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.6 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0033906 | protein tyrosine kinase inhibitor activity(GO:0030292) hyaluronoglucuronidase activity(GO:0033906) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 1.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.0 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.0 | 0.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.0 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.0 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.1 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.0 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 1.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 1.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.9 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 1.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.8 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |